Status:
COMPLETED
Hearing Aid Performance Study for Different Spatial Configurations
Lead Sponsor:
Sonova AG
Conditions:
Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical investigation will extend the evaluation of perception of speech in different listening environments with hearing aids available on the market (from Phonak). The clinical investigation i...
Detailed Description
Hearing aids are designed to amplify and transmit sound to compensate for impaired hearing. The main objective of this medical device is to improve the perception of speech, which can be defined among...
Eligibility Criteria
Inclusion
- Experienced (minimum use duration 6 months)
- Adult (minimum age: 18 years) hearing aid users,
- Written and spoken German,
- Ability to understand instruction,
- Ability to describe listening experiences,
- Ability to attend to the appointments,
- Healthy outer ear,
- Hearing loss within the fitting ranges of the investigational product,
- Informed consent as documented by signature.
Exclusion
- Clinical contraindications deformity of the ear (closed ear canal or absence of pinna),
- Known hypersensitivity or allergy,
- Not willing to wear the hearing aid,
- Fluctuating hearing that could influence the results.
Key Trial Info
Start Date :
March 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2022
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05284903
Start Date
March 21 2022
End Date
July 5 2022
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hörzentrum Oldenburg gGmbH
Oldenburg, Lower Saxony, Germany, 26129